ArticleCurrent drug delivery2025

Reduction-Responsive Polyprodrug Nanoplatform Based on Curcumin for Tumor-Targeted Therapy.

Ziyi Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.